Diffusion Pharmaceuticals Inc. (DFFN) has 20 known insider and institutional holders on record. The largest holder is Feller Paul with 25,812,591 shares. Other notable holders include Gilliam Richard Baxter and Feller Ralph.
DFFN Insider Ownership
Top Holder
Feller Paul
25,812,591 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Feller Paul |
10 Percent Owner, Officer: Chief Executive Officer |
25,812,591 |
2010-04-15 |
|
| 2 |
Gilliam Richard Baxter |
10 Percent Owner |
12,687,975 |
2016-02-19 |
|
| 3 |
Feller Ralph |
10 Percent Owner |
9,329,655 |
2008-03-31 |
|
| 4 |
Rubinstein Jerold H |
Director |
900,000 |
2011-06-03 |
|
| 5 |
Gregoire Sylvie |
10 Percent Owner |
732,039 |
2023-11-09 |
|
| 6 |
Alam John J |
10 Percent Owner, Officer: CEO & President |
729,539 |
2023-11-09 |
|
| 7 |
Simes Stephen M |
Chief Executive Officer |
542,975 |
2014-07-29 |
|
| 8 |
Weinberg Mark A. |
Sr. V.p.- Clinical Development |
521,475 |
2014-08-06 |
|
| 9 |
Jones David Randolph |
Chief Medical Officer |
382,557 |
2016-01-15 |
|
| 10 |
Galloway Christopher D |
Chief Medical Officer |
305,743 |
2022-01-31 |
|
| 11 |
Hornung William Karl |
Chief Financial Officer |
305,743 |
2022-01-31 |
|
| 12 |
Donenberg Philip B |
Director |
271,475 |
2014-07-29 |
|
| 13 |
Kalergis David G |
Chairman and CEO |
262,900 |
2020-01-30 |
|
| 14 |
Gainer John |
Chief Scientific Officer |
239,400 |
2020-01-30 |
|
| 15 |
Blech Isaac |
Director |
204,907 |
2016-09-16 |
|
| 16 |
Schneider John |
Director |
179,105 |
2012-09-14 |
|
| 17 |
Barer Sol J |
Director |
123,287 |
2014-07-29 |
|
| 18 |
Schwartz Yael |
Exe. VP Preclinical Dev. |
119,482 |
2014-07-29 |
|
| 19 |
Sherris David |
Chief Scientific Officer |
119,482 |
2014-07-29 |
|
| 20 |
Levin Alan G |
Director |
83,300 |
2021-07-06 |
|
No ownership data available for DFFN.
